These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21752468)

  • 1. Alternately binding probe competitive PCR as a simple, cost-effective, and accurate quantification method for JAK2V617F allele burden in myeloproliferative neoplasms.
    Morishita S; Komatsu N; Kirito K; Koda AH; Sekiguchi Y; Tsuneda S; Noda N
    Leuk Res; 2011 Dec; 35(12):1632-6. PubMed ID: 21752468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accurate quantitation of JAK2 V617F allele burden by array-based digital PCR.
    Kinz E; Leiherer A; Lang AH; Drexel H; Muendlein A
    Int J Lab Hematol; 2015 Apr; 37(2):217-24. PubMed ID: 24963593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases.
    Rapado I; Albizua E; Ayala R; Hernández JA; Garcia-Alonso L; Grande S; Gallardo M; Gilsanz F; Martinez-Lopez J
    Ann Hematol; 2008 Sep; 87(9):741-9. PubMed ID: 18575865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of JAK2V617F mutation in patients with myeloproliferative disorders with TaqMan-MGB probe].
    Ruan GR; Chen SS; Li LD; Liu YR; Qin YZ; Li JL; Ma X; Wang FR; Jiang Q; Jiang B; Liu KY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2401-4. PubMed ID: 18036317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of standards for quantitative assessment of JAK2 c.1849G>T (p.V617F) allele burden analysis in clinical samples.
    Collier P; Patel K; Waeltz P; Rupar M; Luthra R; Liu PC; Hollis G; Huber R; Verstovsek S; Burn TC
    Genet Test Mol Biomarkers; 2013 May; 17(5):429-37. PubMed ID: 23537216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative method for specific nucleic acid sequences using competitive polymerase chain reaction with an alternately binding probe.
    Tani H; Kanagawa T; Kurata S; Teramura T; Nakamura K; Tsuneda S; Noda N
    Anal Chem; 2007 Feb; 79(3):974-9. PubMed ID: 17263324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification refractory mutation system, a highly sensitive and simple polymerase chain reaction assay, for the detection of JAK2 V617F mutation in chronic myeloproliferative disorders.
    Chen Q; Lu P; Jones AV; Cross NC; Silver RT; Wang YL
    J Mol Diagn; 2007 Apr; 9(2):272-6. PubMed ID: 17384221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concordance of assays designed for the quantification of JAK2V617F: a multicenter study.
    Lippert E; Girodon F; Hammond E; Jelinek J; Reading NS; Fehse B; Hanlon K; Hermans M; Richard C; Swierczek S; Ugo V; Carillo S; Harrivel V; Marzac C; Pietra D; Sobas M; Mounier M; Migeon M; Ellard S; Kröger N; Herrmann R; Prchal JT; Skoda RC; Hermouet S
    Haematologica; 2009 Jan; 94(1):38-45. PubMed ID: 19001280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of single-nucleotide polymorphism allele frequency by alternately binding probe competitive polymerase chain reaction.
    Noda N; Tani H; Morita N; Kurata S; Nakamura K; Kanagawa T; Tsuneda S; Sekiguchi Y
    Anal Chim Acta; 2008 Feb; 608(2):211-6. PubMed ID: 18215653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-round allele specific-polymerase chain reaction: a simple and highly sensitive method for JAK2V617F mutation detection.
    Kannim S; Thongnoppakhun W; Auewarakul CU
    Clin Chim Acta; 2009 Mar; 401(1-2):148-51. PubMed ID: 19135044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative determination of JAK2 V617F by TaqMan: An absolute measure of averaged copies per cell that may be associated with the different types of myeloproliferative disorders.
    Hammond E; Shaw K; Carnley B; P'ng S; James I; Herrmann R
    J Mol Diagn; 2007 Apr; 9(2):242-8. PubMed ID: 17384217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of the JAK2 V617F mutation by LightCycler PCR and probe dissociation analysis.
    Lay M; Mariappan R; Gotlib J; Dietz L; Sebastian S; Schrijver I; Zehnder JL
    J Mol Diagn; 2006 Jul; 8(3):330-4. PubMed ID: 16825505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A simple, rapid, and sensitive method for the detection of the JAK2 V617F mutation.
    Tan AY; Westerman DA; Dobrovic A
    Am J Clin Pathol; 2007 Jun; 127(6):977-81. PubMed ID: 17509995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V617F JAK2 mutation and the myeloproliferative disorders.
    Percy MJ; McMullin MF
    Hematol Oncol; 2005; 23(3-4):91-3. PubMed ID: 16285006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of a Low-Cost, Sensitive PNA Clamping PCR Method for JAK2 V617F Variant Detection.
    Di Francia R; Crisci S; Muto T; Giancola C; Petriccone L; Catapano O; Cummarro A; Pinto A; Frigeri F
    J Appl Lab Med; 2020 Jul; 5(4):643-655. PubMed ID: 32407536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The investigation of JAK2 V617F point mutation in myeloproliferative disorders by allele-specific polymerase chain reaction in combination with sequence analysis].
    Zhang SJ; Li WD; Song JH; Xu W; Qiu HX; Li JY
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2109-12. PubMed ID: 17988529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative detection of Cryptosporidium oocyst in water source based on 18S rRNA by alternately binding probe competitive reverse transcription polymerase chain reaction (ABC-RT-PCR).
    Kishida N; Miyata R; Furuta A; Izumiyama S; Tsuneda S; Sekiguchi Y; Noda N; Akiba M
    Water Res; 2012 Jan; 46(1):187-94. PubMed ID: 22088270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative assay for the detection of the V617F variant in the Janus kinase 2 (JAK2) gene using the Luminex xMAP technology.
    Paradis FW; Simard R; Gaudet D
    BMC Med Genet; 2010 Apr; 11():54. PubMed ID: 20359349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A quantitative assay for JAK2 mutation in 135 patients with chronic myeloproliferative neoplasms].
    Chao HY; Shen YM; Zhang R; Feng YF; Cen JN; Yao L; Shen HJ; Zhu ZL; Xue YQ
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):321-5. PubMed ID: 19799128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.